J&J | Built to matter: oncology startup strategies to stand out in a crowded market

J&J | Built to matter: oncology startup strategies to stand out in a crowded market

This Johnson & Johnson Innovation event brings together investors, pharma leaders, biotech executives and advisors to explore the strategic choices that can make oncology startups more investable, partnerable and attractive to potential acquirers.

Gain practical perspectives on the strategic decisions that can shape an oncology venture’s path forward. The programme will explore investor and buyer expectations, clinical development considerations and the factors that influence successful partnerships.

Register for the event here.

Testimonials

testimonial

ASTP Annual conference is a unique opportunity to take time to exchange best practices among TT professionals and to network at an EU level.

Cécile Cavalade

ULB TTO, Belgium

testimonial

One very long and hard day, but very useful for my work in TTO.

Petr Kubečka

Palacký University Olomouc, Czech Republic

testimonial

Great atmosphere to learn and to share experiences.

Maria Ruiz Novales

Interface-Enterprises - University of Liege, Belgium

testimonial

I really like the course and the networking. I would like to come again.

Nancy Goel

Qatar Foundation, Qatar

testimonial

The best opportunity to learn and discuss common issues and interests directly with peers.

Ian Nicoud

LURIS, Netherlands